Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
(Score: 2) by krishnoid on Monday February 11 2019, @07:00AM
I think in a lot of cases, they overcharge so they can negotiate down, and to try to cover some of the costs of indigent people who don't have anything they can collect. At least they provided medical care, though. Your insurance, though, all they do is have a computer spit out random numbers and then justify them with bad explanations.*
Seems like this is exactly the kind of thing local news is good at exposing, especially since they sometimes have to look for stories that aren't already all over the Internet already.
* Maybe it was a buy-one, get the next two cheap sale-ine.